PMID: 18183054Jan 10, 2008Paper

Patient-guided crisis admissions for severe psychotic conditions

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Stig Heskestad, Margrete Tytlandsvik

Abstract

Standard treatment for psychotic conditions has been criticized for being inflexible, with too many involuntary admissions and too little patient involvement. Two of 11 beds in a unit for schizophrenic patients at a psychiatric centre were converted to crisis beds. Patients who were known by the centre were given the right (through contracts) to use these beds without being referred by their primary care physician. Stays were limited to five days, with 14 days required between each stay. Data were obtained on the first 18 patients to complete at least a year on the program. Inpatient stays, including involuntary admissions, were compared to the same time frame before implementation of the program. The number of admissions rose, but the number of days hospitalized fell by 33%. Involuntary hospitalization days were approximately cut in half. On the average, patients used the crisis beds just under five times per year, with an average duration of 2.5 days. By contracting to ensure patients' rights and by lowering the threshold for admission, patients and families experience greater autonomy and security. This explains the paradox that increased accessibility of care actually reduces the use of beds. The study shows that seriously ...Continue Reading

Associated Clinical Trials

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.